ContraVir Pharmaceuticals, Inc.
399 Thornall Street
Edison, NJ 08837
| June 13, 2019 |
VIA EDGAR
United States Securities
and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Dorrie Yale
Re: ContraVir Pharmaceuticals, Inc.
Form S-1, as amended
File No. 333-231604
Dear Ms. Yale:
ContraVir Pharmaceuticals, Inc. (the “Company”) hereby respectfully withdraws its request, dated June 12, 2019, that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:30 p.m., Eastern Time, on Thursday, June 13, 2019. The Company intends to submit a revised acceleration request at a later date.
Please contact Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 if there are any questions with respect to this request.
| Thank you, | |
|
| |
| CONTRAVIR PHARMACEUTICALS, INC. | |
|
|
|
|
|
|
| By: | /s/ Robert Foster |
| Name: | Robert Foster |
| Title: | Chief Executive Officer |
